Nonmyeloablative Stem Cell Transplant in Elderly
NCT00382759 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2009-08-03
Summary
The study aimed to evaluate the efficacy of a nonmyeloablative conditioning consisting of fludarabine and total body irradiation in patients older than 60 years of age
Conditions
Interventions
- PROCEDURE
-
stem cell transplant
Sponsors & Collaborators
-
Azienda Ospedaliera San Giovanni Battista
lead OTHER
Principal Investigators
-
michele falda, md · ospedale san giovanni battista
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-03-31
- Primary Completion
- 2007-03-31
- Completion
- 2007-03-31
Countries
- Italy
Study Locations
More Related Trials
-
Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma
NCT00781170 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Gilteritinib in Combination With FLAI as Induction Therapy of FLT3-positive Acute Myeloid Leukemia
NCT06667973 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia
NCT00462332 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia
NCT00052299 ·Status: COMPLETED ·Phase: PHASE3
-
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
NCT01529827 ·Status: COMPLETED ·Phase: PHASE2
-
Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia
NCT00003145 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of FT14 Conditioning for Allogeneic HSCT in Acute Myeloid Leukemia
NCT07232953 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT
NCT03977103 ·Status: UNKNOWN ·Phase: PHASE2
-
Allo vs Hypomethylating/Best Supportive Care in MDS (BMTCTN1102)
NCT02016781 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute Leukemia
NCT01814488 ·Status: COMPLETED ·Phase: PHASE2
-
Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib
NCT00036738 ·Status: COMPLETED ·Phase: PHASE2
-
Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders
NCT04761770 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML
NCT02926586 ·Status: COMPLETED ·Phase: PHASE4
-
GITMO AML/MDS-Relapse Registry Study
NCT06790680 ·Status: COMPLETED
-
Efficacy of G-CSF-Priming in Elderly AML Patients
NCT00199147 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment of Adult ALL With an MRD-directed Programme.
NCT00358072 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia
NCT00002719 ·Status: COMPLETED ·Phase: PHASE3
-
Decitabine Combined With Unrelated Cord Blood Transplantation for Elderly Patients With AML
NCT03913312 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
AML Patients Bearing FLT3 Mutations Based on Peripheral Blast Clearance
NCT04174612 ·Status: UNKNOWN ·Phase: PHASE3
-
Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen for Elderly Patients With Acute Myeloid Leukemia: A Phase II Single-Arm Multicenter Study
NCT05258799 ·Status: RECRUITING ·Phase: NA
-
Standard vs. Reduced-Intensity Conditioning in Patients With Acute Myeloid Leukemia in First Remission
NCT00150878 ·Status: TERMINATED ·Phase: PHASE3
-
Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients
NCT04587856 ·Status: RECRUITING ·Phase: NA
-
S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
NCT00053014 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy Study of Microtransplantation to Treat Elderly Acute Myeloid Leukemia
NCT02171117 ·Status: UNKNOWN ·Phase: PHASE3
-
Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS
NCT00038831 ·Status: COMPLETED ·Phase: PHASE1/PHASE2